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Craniofacial defects involving the lip and/or palate are among the most common human birth defects.
X-linked cleft palate and ankyloglossia results from loss-of-function mutations in the gene encoding the
T-box transcription factor TBX22. Further studies show that TBX22 mutations are also found in around 5%
of non-syndromic cleft palate patients. Although palate defects are obvious at birth, the underlying develop-
mental pathogenesis remains unclear. Here, we report a Tbx22
null mouse, which has a submucous cleft palate
(SMCP) and ankyloglossia, similar to the human phenotype, with a small minority showing overt clefts. We
also ﬁnd persistent oro-nasal membranes or, in some mice a partial rupture, resulting in choanal atresia.
Each of these defects can cause severe breathing and/or feeding difﬁculties in the newborn pups, which
results in 50% post-natal lethality. Analysis of the craniofacial skeleton demonstrates a marked reduction
in bone formation in the posterior hard palate, resulting in the classic notch associated with SMCP. Our
results suggest that Tbx22 plays an important role in the osteogenic patterning of the posterior hard
palate. Ossiﬁcation is severely reduced after condensation of the palatal mesenchyme, resulting from a
delay in the maturation of osteoblasts. Rather than having a major role in palatal shelf closure, we show
that Tbx22 is an important determinant for intramembranous bone formation in the posterior hard palate,
which underpins normal palate development and function. These ﬁndings could have important implications
for the molecular diagnosis in patients with isolated SMCP and/or unexplained choanal atresia.
INTRODUCTION
Cleft palate (CP) is a common birth defect with an incidence
of 1:1500 (1). CP may present either as an isolated congenital
abnormality or in association with other clinical features, as
part of a syndrome (2). Submucous cleft palate (SMCP)
forms a clinically important sub-group, which may be at
least as common as overt CP, with a reported incidence of
1:1250 (3) to 1:5000 (4). SMCP can be characterized as
biﬁd uvula, a notch in the posterior hard palate and/or
palatal muscle diastasis (5). In the latter, the palatine muscle
inserts incorrectly onto the hard palate causing velopharyngeal
insufﬁciency (VPI) (6). Whether muscle diastasis is caused by
a defect in palate myogenesis, by a malformation of the pos-
terior palatal bone, or both is currently not clear. When one
or more of the characteristic anatomical features is present
without VPI, the term occult SMCP is sometimes used.
SMCP-related VPI is considered part of the clinical spectrum
of CP and is a common cause of feeding difﬁculties, speech
problems and otitis media-related hearing loss.
Human TBX22 encodes a T-box protein containing tran-
scriptional repressor activity and is mutated in X-linked cleft
palate and ankyloglossia (CPX; MIM303400) (7–10). CPX
is an X-linked semi-dominant craniofacial disorder affecting
male patients and approximately one-third of female carriers
(7). Ankyloglossia without a CP is seen in many carrier
females and occasionally in males, indicating a partial pene-
trance (8,11). Similarly, a detectable ankyloglossia is not
always present in CPX patients who are affected by a CP.
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variation which ranges from ankyloglossia alone, SMCP,
biﬁd uvula or cleft of the soft and hard palate, all with or
without ankyloglossia (7–9,12). Loss-of-function mutations
include frame shift, splice site and nonsense mutations,
along with missense changes which have been shown to
impair DNA binding and sumoylation (13). Sequence vari-
ation in the TBX22 promoter has recently been associated as
a risk factor for CP, but predominantly in patients with anky-
loglossia (14), although coding region mutations are also
found in 4–8% of non-syndromic cases of CP (8,9).
TBX22 is part of the TBX1 sub-family and shares a close
evolutionary origin with TBX15 and TBX18 (15). Members
of this gene family (Tbx1, Tbx15, Tbx10, Tbx18 and Tbx22)
are all expressed in the craniofacial area, and mutation of
Tbx1 and Tbx10 results in CP phenotypes (16,17). Addition-
ally, haploinsufﬁciency of the TBX1 gene is the major gene
responsible for DiGeorge syndrome, where one of the features
is CP (DGS; MIM188400). Expression of Tbx22 in mouse and
chicken is seen in the posterior palate, caudal tongue, nasal
mesenchyme, extra-ocular mesenchyme (Supplementary
Material, Fig. S1) and early somites (12,18,19). This pattern
correlates well with the phenotypic characteristics found in
CPX patients but suggests additional roles for TBX22 in
development. Although the defects associated with mutations
in TBX22 are obvious at birth, the underlying developmental
pathogenesis remains unclear.
Here,wehavecreatedaTbx22
nullmouse,whichhasaSMCP,
similar to the human phenotype. In addition to ankyloglossia,
we ﬁnd oro-nasal defects including choanal atresia. The latter
defect causes post-natal lethality in 50% of mutant mice.
Analysis of the craniofacial skeleton demonstrates a marked
reduction in bone formation of the vomer and in the posterior
hard palate, resulting in the classic notch associated with
SMCP. Ossiﬁcation is severely reduced after condensation of
the palatal mesenchyme, resulting from a delay in the differen-
tiation and/or maturation of osteoblasts. Rather than being
involved in palatal shelf closure, we show that TBX22 is a
major determinant for intramembranous bone formation in the
posterior hard palate, which underpins both normal palate
development and function.
RESULTS
Generation of mice lacking Tbx22
To study the molecular and cellular pathogenesis of CPX, we
disrupted mouse Tbx22 by gene targeting (Supplementary
Material, Fig. S1). In brief, we introduced loxP sites ﬂanking
the ﬁrst three exons to create a ﬂoxed line. Tbx22
ﬂox animals
did not show any phenotypic abnormalities. Subsequently,
we removed the ﬁrst three exons, including the start codon,
the N-terminal repression domain, nuclear localization signal
and part of the T-box domain, using a bactin-Cre deleter
strain to create a Tbx22
null allele. This allele was bred onto
a CD1 background. After initial inspection of Tbx22
null
embryos (homozygous Tbx22
2/2 females or hemizygous
Tbx22
2/Y males) at embryonic day (E) 18.5 no palatal pheno-
type was immediately obvious. However, we then noticed a
Mendelian imbalance in the survival of Tbx22
null pups after
birth. Approximately 50% of these animals struggle to
breathe and/or fail to suckle effectively resulting in death
within 24 h. The stomach and intestine were ﬁlled with air
rather than milk (Fig. 1A), similar symptoms to those
described for other mouse models of CP (e.g. Tgfb3
null)
(20). Close inspection of the orofacial morphology of
Figure 1. Tbx22
null mice show submucous cleft palate. (A) Approximately 50% of mutant animals die within 24 h post-partum, exhibiting breathing problems
and inability to suckle. Their overall anatomy is grossly normal but with air rather than milk in the stomach. (B) Male hemizygous Tbx22
null (2/Y) and female
homozygous animals (data not shown) are affected, displaying submucous (b2) or overt (b3) clefts. SMCP can be identiﬁed by the irregular and more widely
spaced location of the rugae. (C) Submucous or overt cleft palate can be observed in E15.5 coronal sections through the posterior end of the hard palate (dotted
line). Bone mineralization (pink osteoid) can be seen in the lateral parts of the wild-type fused palate (arrow), while in the SMCP and CP mice, ossiﬁcation is
severely reduced. Pa ¼ palate, PS ¼ pre-sphenoid, T ¼ tongue, A ¼ anterior, P ¼ posterior.
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null embryos, showed an aberrant pattern of rugae in the
posterior half of the hard palate, combined with an area of
translucency in the posterior portion (Fig. 1B). A small
number of Tbx22
null embryos (2/30) were identiﬁed with an
overt CP (Fig. 1B). Detailed analysis of the secondary palate
at E15.5 revealed that although fusion along the entire
anterior–posterior axis was complete, the posterior hard
palate was affected by severely reduced bone formation in
all of the mutants analyzed (n ¼ 30). This is illustrated by
the lack of ossiﬁed bone matrix in haematoxylin and eosin
(H&E) stained coronal sections of mutant compared with
wild-type embryos (Fig. 1C).
Anomalies of the craniofacial skeleton
At E18.5, skeletal preparations of Tbx22
null mutants stained
for bone and cartilage show an abnormal palatine process of
the palatal bone and an under-developed vomer although the
surrounding craniofacial skeleton is normal (Fig. 2). The pala-
tine process provides the skeletal contribution to the posterior
hard palate while the vomer sits anterior and rostral to the
palate and is the supporting structure for the nasal cartilage
and the secondary hard palate. The scale of bone loss can be
seen in the bone surfaces generated from microCT scans of
E18.5 embryos (Fig. 2B and Supplementary Material,
Movies S1–S6). The mutant vomer is reduced in size and
has not fused in the midline. Posterior palatal bone has
formed in the dorsal–ventral direction but has not progressed
in the lateral–medial direction. The total size of the vomer and
palatine process is reduced by 74% (vomer) and 68% (palate)
(n ¼ 4). Together, these results are consistent with a SMCP
phenotype.
Palatine bone deﬁciency results from a reduction
in osteoblast maturation
To investigate the molecular mechanisms involving TBX22 in
craniofacial development, we examined the expression of a
number of genes known to play roles in palate development
such as Pax9, Snail, Msx1, Msx2, Bmp4, Osr1 and Tgfb3.
With the exception of Pax9 (discussed below) and a modest
increase of Msx2 in the posterior tongue, no signiﬁcant differ-
ences in the levels or patterns of expression were detected in
the developing craniofacial tissues of Tbx22
null embryos (Sup-
plementary Material, Figs S2 and S3). Next, we investigated
whether the resultant effect of TBX22 loss on palatine bone
formation was through interference with the osteogenic
process. Close inspection of coronal sections of the head at
E15.5 shows a region of condensed mesenchyme in the
mutant, but a complete lack of mineralized bone, as opposed
to the wild-type control (Fig. 3A). This result implies that
the impaired ossiﬁcation is a direct result of osteoblasts
failing to mature in the Tbx22
null mutant. Alkaline phospha-
tase activity, a marker for osteoblast activity is signiﬁcantly
reduced in the mutant palate, indicating that osteoblasts do
not reach a mature enough status where they are capable of
bone mineralization (Fig. 3B). The alkaline phoshatase
activity in control sections shows that osteoblasts have differ-
entiated and are actively involved in the ossiﬁcation process.
Although normal activity can be seen in the mutant’s
mandible, forming around Meckel’s cartilage (Fig. 3B) and
at anterior regions of the secondary palate (data not shown),
only very low activity could be observed in the developing
posterior palate.
To determine the effect of TBX22 loss on osteoblast differ-
entiation, we analyzed the expression of Runx2, an early deter-
minant of the osteoblast lineage from mesenchymal cells (21)
in mutant animals. No difference in Runx2 expression was
observed at E13.5 between mutant and wild-type posterior
palates (Supplementary Material, Fig. S3), while at E15.5
differences reﬂect the poor development of the bone matrix
in Tbx22
null mutants (Fig. 3C). The area of expression is
clearly smaller than the condensed mesenchyme weakly
expressing alkaline phoshatase, indicating a reduced number
of differentiated osteoblasts. Expression of Runx2 in E15.5
Tbx22
null posterior palate resembles the Runx2 expression
pattern in E14.5 wild-type embryos (data not shown), indicat-
ing a delay of at least 1 day.
Tbx22
null mice have ankyloglossia and choanal atresia
Further comparative histological analysis of craniofacial struc-
tures between wild-type and Tbx22
null mouse embryos
revealed a more anterior caudal attachment of the tongue to
the mandible (Fig. 4A). This is similar to the shortened frenu-
lum, frequently seen in human CPX patients with ankyloglos-
sia. This feature was consistent in all mutant animals studied
(n ¼ 30), but does not extend to the tip of the tongue, repre-
senting a mild form of ankyloglossia. Another defect, this
time not expected based on known CPX phenotypes, was
choanal atresia. The choanae are located at the anterior end
of the medial nasal prominence allowing air to ﬂow from
the nasal cavity into the oral pharynx, reaching the trachea.
However, in Tbx22
null embryos, a persistent oro-nasal mem-
brane (Fig. 4B), which narrows or blocks this passage, restricts
nasal breathing. This defect is clearly illustrated in microCT
scans of E18.5 embryos (Supplementary Material, Fig. S4).
In severe cases, the choanae are blocked along their entire
anterior–posterior length, although in milder cases only the
posterior part of the choanae is obstructed. It is likely that
the anterior position of the membrane will have a marked
effect on the survival of the newborn pups. The most severe
cases are incapable of nasal breathing, causing gasping for
air and making suckling impossible for affected pups
(Fig. 5A). Indeed, an investigation of Tbx22
null newborn
pups suggests that the choanal phenotype is likely to be the
main cause of the post-natal lethality. Choanal atresia was
absent in all of the surviving male null animals analyzed but
present in those that suffered a premature demise (Fig. 5B).
In older, weaning stage animals, we observed that surviving
mutants had a persistent notch in the posterior hard palate
(Fig. 5C) indicating the SMCP, but with normal choanae. At
E13.5, Tbx22 expression is clearly detected in the medial and
lateral nasal mesenchyme at the site where the oro-nasal ﬁns
occur (Supplementary Material, Figs S1 and 5D). In wild-type,
Pax9 expression overlaps in this region with Tbx22, although in
the mutant the expression is both upregulated and the domain
enlarged to span across the persistent oro-nasal membrane
(Fig. 5D). These data are consistent with a possible role for
PAX9 in the timely rupture of the oro-nasal membrane.
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R cassette
is retained on the Tbx22
null allele, however, no effects were
attributable to its presence since identical phenotypes were
also observed in mutants following in vivo excision with an
Flp-deleter (data not shown). Similarly, the same spectrum
of phenotypes and severity range was observed when the
Tbx22
null allele was crossed onto 129/SvJ and C57BL/6J
strains and bred to .95% congenicity.
DISCUSSION
Tbx22
null mice show multiple craniofacial defects that include
submucous or overt CP, choanal atresia, reduced vomer and
ankyloglossia, which are all consistent with its known
expression pattern (12,18,19). Ankyloglossia was expected
as it is a characteristic phenotype, frequently associated with
CPX syndrome (8,9). Contrary to the variable penetrance in
Figure 2. Loss of Tbx22 causes bone phenotypes in the palate and vomer. (A) Ventral view of skeletal preparations with Alizarin Red (bone) and Alcian Blue
(cartilage) of E18.5 embryos reveal reduced posterior palatal bones (black arrowhead), although anterior (maxillary) palatal bones (white arrowhead) are normal
(a2,6). Additionally, the vomer is reduced (asterix in a7), visible after removing the maxillary palatine processes (black lines indicate cut surfaces). Coronal
sections (a4,8; approximately at the level of the dotted lines in a2,6) stained with H&E show the mineralized palatine bone in wild-type embryos, although
there is severely reduced mineralization in the Tbx22
null embryo (black arrows). (B) Bone 3D surfaces generated from microCT scans of E18.5 day heads
reveal the reduced size of the vomer and palatine bone (green). Occipital bone surfaces have been removed to facilitate dorsal view. BS ¼ basisphenoid,
BO ¼ basoccipital, Ma ¼ mandible, PS ¼ presphenoid, T ¼ tongue, A ¼ anterior, P ¼ posterior.
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null mice
studied. The extent of the defect is variable but never as pro-
minent or severe as that described in the Lgr5 loss-of-function
mutant (22). In these mice the defect is reported to be lethal,
with null animals dying within 24 h of birth with empty, dis-
tended stomachs, ﬁlled with air. This is not unlike the
Tbx22
null mice that fail to thrive except that the tongue
defect is considerably milder. We suggest that other defects
are more likely to be responsible for the prenatal demise
observed.
Malformation of the vomer bone has not previously been
discussed in relation to X-linked CP but has certainly been
associated with both CP and SMCP. In a study of 30 patients
undergoing surgery for SMCP, all were found to have vomer-
ine malformations with the most frequently observed defect
being a failure in vomer fusion with the rostral part of the
palatal shelves (23). Similarly in a small series of fetuses the
vomer was found to be poorly developed and also not fused
in the region of the maxillary process in those with CP,
which contrasted to the normal fetuses studied (24). We
have not studied Tbx22
null mice at adult stages, but obser-
vations from around P12 also show the vomer to be severely
underdeveloped. The vomer is thought to play a role in
support of the secondary palate and also the development
and separation of the choana. However, as choanal atresia is
usually associated with a thickening of the vomer it
may be more likely that these defects are independent (25).
Nevertheless, the relevance of the vomer to SMCP and the
pathology of VPI are currently unknown and in need of
further investigation.
Our data, at least on the surviving Tbx22
null mice, suggests
that they have an occult SMCP, where the palatal bone is
affected, but the insertion of the palatine muscles into the apo-
neurosis, and the function of the palate, remains intact. Analy-
sis of the posterior palatal bone has shown a distinct reduction
of alkaline phoshatase in the development of the palatal bone,
while expression of Runx2 was intact at early stages, up to and
including E14.5. Interestingly, TBX3 has recently been ident-
iﬁed as a negative regulator of osteoblast differentiation in
limb development with T-box binding sites identiﬁed in the
regulatory regions of both Runx2 and Osterix genes (26).
Although we cannot exclude the possibility that the expression
of Runx2 is impaired by E15.5, the gross differences in palatal
morphology between wild-type and mutant at this stage are
already too large to make a direct comparison. These results
therefore indicate a role for TBX22 in Runx2-independent
and late differentiation of osteoblasts in the posterior palate.
A delay of at least one embryonal day (as mirrored by the
alkaline phoshatase expression) seems sufﬁcient for a
reduction in bone formation and function of the palate.
Whereas none of the craniofacial expressed genes we inves-
tigated were noticeably up or down regulated in Tbx22
null
palates, we did observe an upregulation and broadening of
the expression domain of Pax9 throughout the persistent
Figure 3. Reduced bone formation in the posterior hard palate is due to delayed maturation of osteoblasts. (A) H&E stained coronal sections of E15.5 embryos.
In the wild-type, osteogenesis of the posterior palate is progressing normally with mineralized bone matrix visible (pink osteoid) on either end of the nasal
passage (a1,2,3). In contrast, although condensation of mesenchyme can be observed in the Tbx22
null, mineralization is absent (a4,5,6). (B) Alkaline phosphatase
activity assay on coronal sections of E15.5 embryos. In the wild-type, enzyme activity (purple) is observed in the osteoblasts on the edges of the posterior pala-
tine osteogenic centre (arrow) (b1,2). In the Tbx22
null, alkaline phoshatase staining is severely reduced (b3,4). Sections are counter-stained with Alcian Blue.
(c) In situ hybridization of coronal sections for Runx2. Expression can be detected in the developing mandible, palate and tooth buds in wild-type embryos
(c1,2). Tbx22
null mutant embryos show reduced expression of Runx2 in the posterior palate (c3,4). Ma ¼ mandible, M ¼ Meckel’s cartilage, Pa ¼ palate,
PS ¼ presphenoid, T ¼ tongue.
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although both human and mouse Pax9 promoters contain puta-
tive T-box binding sites in an area of sequence homology
(.80%). Inappropriate expression of Pax9 in the oro-nasal
membrane could provide a possible explanation for its persist-
ence since it is believed to promote cell survival, both by reg-
ulating the expression of genes involved in mediating cell
proliferation and resistance to apoptosis (27). Although
choanal atresia is not currently a recognized feature of CPX,
this may in part be due to selection bias and will require
speciﬁc investigation in the future. Choanal atresia has pre-
viously been described in combination with overt CP in
CHARGE syndrome, which usually also includes other fea-
tures such as coloboma, heart defects and growth restriction.
About 60–80% of patients are estimated to be associated
with haploinsufﬁciency of the gene CHD7 (28) and mice
mutant for this gene provides a useful model (29). Choanal
atresia has also been described in the Raldh3 null mouse
mutant, which presents with a similar post-natal lethal respir-
atory distress phenotype, where the pups become cyanotic and
die within 10 h (30). It is suggested that the persistence of the
nasal ﬁns may result from impairment to normal retinoic acid
synthesis, which in turn down-regulates Fgf8 expression in the
nasal ﬁns. The authors also demonstrate the prevention of
choanal atresia using a maternal non-teratogenic dose of reti-
noic acid.
Figure 4. Phenotypic analysis of Tbx22
null mice. Embryos were collected at E15.5 and coronal sections were stained with H&E. (A) Ankyloglossia, or tongue-tie
is observed in all mutant embryos (closed arrows in a2,3,5,6). In Tbx22
null mutants (a5,6), the tongue is usually attached caudally, at least as anteriorly as the
incisive foramen, which is the transition between the primary and secondary palate, while at that point the tongue in the wild-type embryos is free (a4).
(B) Choanal atresia is observed in mutant embryos with variable severity. In Tbx22
null embryos, a persistent oro-nasal membrane (arrows in b3,5,6) can be
observed. M ¼ Meckel’s cartilage, NS ¼ nasal septum, Pa ¼ palate, PP ¼ primary palate, T ¼ tongue, A ¼ anterior, P ¼ posterior.
4176 Human Molecular Genetics, 2009, Vol. 18, No. 21In contrast to many other CP mouse models where the
speciﬁc genetic background had signiﬁcant impact on either
penetrance or severity, for example as described in the
Tgfb3 mutant (31), our analysis in CD1, 129Sv and C57Bl6
strains has shown similar phenotypes and with a similar pene-
trance for each. It is also interesting to note that unlike in the
human, female heterozygote mutant mice are all unaffected
whereas the null females are the same as male null
animals. It will be interesting to determine whether these
differences are due to additional genetic or environmental
factors or differences in X-inactivation between mouse and
human.
In summary, the Tbx22
null mouse has developmental defects
similar to those found in patients with CPX and provides a
new and unique model to understand the SMCP phenotype.
Unlike overt clefts, this clinically recognizable form of
SMCP has not been extensively studied in the mouse with
only Tshz1 and Tgfbr2 mutants described with either cleft or
premature truncation of the soft palate respectively (32,33).
Both of these defects are restricted to soft palate development
Figure 5. Choanal atresia is the likely cause of death in Tbx22
null mice. (A) In E18.5 embryos the choanal defect can be seen clearly in coronal (a1,2) as well as
sagittal (a3,4) sections of the head. In the null animal (a2,4) the persistent oro-nasal membrane (black arrowhead) blocks the air-ﬂow (white arrow) from the
nostril into the oral pharynx and eventually the trachea. (B) When analyzing Tbx22
null littermates we observe that around half suckle successfully (b2),
while the other half perish within 24 hours with breathing difﬁculties and air in the stomach (b4). (C) Skeletal preparations with Alizarin Red and/or Alcian
Blue at postnatal day 12 in wild-type and Tbx22
null survivors show the extent of the submucous cleft as a notch in the posterior end of the hard palate at
the cartilage between the basisphenoid and the presphenoid (asterisk). Palatine bone size is further reduced as is evident from the incomplete fusion with the
maxillary part of the palatine bone (arrowhead). (D) In situ hybridizations showing expression of Tbx22 (pink) and Pax9 (blue) in lateral and medial nasal
mesenchyme, either side of the choana. In Tbx22
null embryos, expression of Pax9 can be observed in the persistent oro-nasal membrane. BS ¼ basisphenoid,
Mo ¼ molar, MP ¼ maxillary process, NC ¼ nasal cavity, Pa ¼ palate, PP ¼ palatine process, T ¼ tongue.
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common cause of human SMCP. Since other mouse models
for CP are frequently reported with less than 100% penetrance,
our data suggests it might also be valuable to investigate the
non-penetrant animals for intramembranous bone formation.
The Tbx22
null model, clearly argues that SMCP is a continuous
part of the same phenotypic spectrum. The precise molecular
mechanism of the TBX22 transcriptional signaling cascade
still remains to be determined but a failure in palatal osteoblast
differentiation and maturation has been highlighted. A review
of all CPX cases known to us suggests that SMCP is at least as
common as overt CP (unpublished observations). This fre-
quency might turn out to be even higher given a potential
bias towards screening for TBX22 mutations in overt CP
cases. This study provides important new insight to further
our understanding of common craniofacial birth defects and
to initiate a proper exploration of the relationship between
overt CP and SMCP.
MATERIALS AND METHODS
Generation of the Tbx22
null allele
The Tbx22 targeting vector was generated by cloning genomic
fragments, a loxP site and a loxP-frt-Neo-frt cassette into the
pSP72 vector (Fig. 1A). The integrity of the targeting con-
struct was conﬁrmed by DNA sequencing. The vector was lin-
earized and electroporated into 129/Sv embryonic stem (ES)
cells (Kindly provided by E. Robertson). Successfully targeted
G418 resistant clones were identiﬁed by PCR and conﬁrmed
by Southern blot analysis. Positive clones were used to gener-
ate chimera in C57BL/6J mice. Germline ﬂoxed mice
(Tbx22
tm1(ﬂox/exon0-2/NEO)Sta) were bred to b-actin-Cre mice
to remove the ﬁrst three exons and create a Tbx22 deleted
strain. This created the Tbx22
tm1.1(b-actin/Dexon0-2/NEO)Sta
allele, which we called Tbx22
null. Subsequently, mice were
backcrossed onto CD1, 129/SvJ and C57BL/6J strains to
.95% congenicity.
Histological analysis
Embryos were collected from Tbx22
þ/2 females crossed with
Tbx22
2/Y males at different embryonic time points. Litters
were dissected and ﬁxed in 4% paraformaldehyde overnight.
Embryos were parafﬁn-embedded, sectioned and stained with
H&E.Alkalinephosphataseassaywasperformedbyincubating
deparafﬁnizedsectionswith0.5 mg/mlNBT/BCIPsolutionand
counterstaining with Alcian Blue. Skeletal preparations were
performed by removing the skin, ﬁxing heads in 100% ethanol
overnight, and staining in Alizarin Red and Alcian Blue sol-
ution, followed by clearing in 1% KOH for several days.
MicroCT imaging
Specimens were prepared and scanned as previously described
(34). In brief, ﬁxed fetuses were wrapped with a loose thin
sponge and immersed in 1 PBS in a plastic container then
scanned on volumetric microCT scanner at 27 mm isometric
voxel resolution using an eXplore Locus RS Small Animal
MicroCT Scanner (GE Healthcare, London, ON, Canada).
This volumetric scanner uses a 3500   1750 CCD detector
for Feldkamp cone-beam reconstruction. The platform inde-
pendent parameters of current, voltage and exposure time
were kept constant at 450 mA, 80 kVP and 2000 ms, respect-
ively. Additional scan parameters include 900 evenly spaced
view angles (views) and 10 frames per view. Scan time was
400 min per sample. Images were reconstructed with the man-
ufacturer’s proprietary EVSBeam software. Images were ana-
lyzed and bone surfaces generated using Microview (version
2.0.29), ImageJ (version 1.41) and VAM (version 0.8.13).
In situ hybridization
For in situ hybridization, embryos were ﬁxed overnight in 4%
paraformaldehyde in PBS, dehydrated through graded alco-
hols, embedded in parafﬁn wax and sectioned at 8 mm thick-
ness. Non-radioactive RNA in situ hybridization of tissue
sections was performed as previously described (35).
Dioxigenin-labeled Tbx22 antisense riboprobe was generated
with the In vitro Transcription kit (Roche Applied Science),
and anti-digoxigenin-AP antibody (1:1000) (Roche Applied
Science) was used to detect the hybridization signals.
URL
OMIM, http://www.ncbi.nlm.nih.gov/omim/.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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